Sort
16,300 grants matching “fatty liver disease”
Mechanisms of Atherogenesis in Insulin Resistance
$2,130,062Ira A Tabas · Columbia University Health Sciences · P01 · FY2020 · HL
Mechanisms of Atherogenesis in Insulin Resistance
$2,130,062Ira A Tabas · Columbia University Health Sciences · P01 · FY2019 · HL
MOLECULAR GENETIC APPROCHES IN ATHEROSCLEROSIS RESEARCH
$2,113,525University Of California Los Angeles · P01 · FY2000 · HL
Identification of human genes of iron homeostasis
$2,104,903Caroline Philpott · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Mechanisms of Atherogenesis in Insulin Resistance
$2,103,765Ira A Tabas · Columbia University Health Sciences · P01 · FY2016 · HL
Mechanisms of Atherogenesis in Insulin Resistance
$2,103,765Ira A Tabas · Columbia University Health Sciences · P01 · FY2017 · HL
Biological role and pharmacology of EXPERA family proteins and their effect onsterol homeostasis
$2,102,917Assaf Alon · Yale University · R35 · FY2025 · GM
Organized Lipid Matrix: Fatty Acids and Choline in CF
$2,101,037Walter A Shaw · Avanti Polar Lipids, Inc. · R44 · FY2006 · DK
A 3D biomimetic liver sinusoid construct for predicting physiology and toxicity
$2,099,717D. Lansing Taylor · University Of Pittsburgh At Pittsburgh · UH3 · FY2014 · TR
A Cardiovascular-NASH disease nexus: Common Mechanisms and Treatments?
$2,078,938Christopher K Glass · University Of California, San Diego · P01 · FY2024 · HL
Mechanisms of Atherogenesis in Insulin Resistance
$2,072,208Ira A Tabas · Columbia University Health Sciences · P01 · FY2015 · HL
Identification of human genes of iron homeostasis
$2,069,637Caroline Philpott · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Drug Metabolizing Enzymes In Humans And Animal Models
$2,068,287Joyce Goldstein · National Institute Of Environmental Health Sciences · ZIA · FY2011 · ES
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases
$2,063,799T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration
$2,062,691Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2023 · DA
Mechanisms of Atherogenesis in Insulin Resistance
$2,061,690Ira A Tabas · Columbia University Health Sciences · P01 · FY2014 · HL
Systems Biology of Insulin Resistance
$2,057,424Roger J Davis · Univ Of Massachusetts Med Sch Worcester · R24 · FY2014 · DK
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury
$2,054,483Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA
Longevity and Stress Resistance
$2,054,477Stephen F Vatner · Univ Of Med/Dent Of Nj-Nj Medical School · P01 · FY2010 · AG
Impact of FGF21 on healthspan and lifespan
$2,054,233Vishwa Deep Dixit · Yale University · P01 · FY2016 · AG
Epidemiologic studies of maternal and early life metabolic risk
$2,043,853Madhumita Sinha · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
TAKEOFF: Targeting Aging with Ketone Ester in Older adults for Function in Frailty
$2,039,697John C Newman · Buck Institute For Research On Aging · RF1 · FY2025 · AG
Advanced Non Invasive Vascular Imaging Methods
$2,030,394Ahmed Gharib · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Impact of FGF21 on healthspan and lifespan
$2,024,695Vishwa Deep Dixit · Yale University · P01 · FY2017 · AG
Xenobiotic receptors
$2,021,694Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA